← Back
$APRE All transactions

Aprea Therapeutics, Inc.

A

$ Value

$0

Shares

4,185

Price

$0

Filed

Jun 9

Insider

Name

Duey Marc

Title

CIK

0001925150

Roles

Director

Transaction Details

Transaction Date

2025-06-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,185

Footnotes

These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose. | The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Filing Info

Accession No.

0001104659-25-057809

Form Type

4

Issuer CIK

0001781983

Duey Marc's History

Date Ticker Type Value
2025-12-10 APRE $25K
2025-12-10 APRE
2025-06-05 APRE A $0
2025-06-05 APRE A $0

Other Insiders at APRE (90d)

Insider Bought Sold Last
Peters Richard $100K 2026-03-31
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
$30K 2026-03-31
Gilad Oren
President/CEO
$25K 2026-03-12